You are here

  • Home
  • Archive
  • Volume 79, Issue 7
  • Therapeutic drug monitoring of adalimumab in RA: no predictive value of adalimumab serum levels and anti-adalimumab antibodies for prediction of response to the next bDMARD

Citation Tools

Article menu
Download PDFPDF
Rheumatoid arthritis
Therapeutic drug monitoring of adalimumab in RA: no predictive value of adalimumab serum levels and anti-adalimumab antibodies for prediction of response to the next bDMARD

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Ulijn E, den Broeder N, Wientjes M, et al
Therapeutic drug monitoring of adalimumab in RA: no predictive value of adalimumab serum levels and anti-adalimumab antibodies for prediction of response to the next bDMARD
Annals of the Rheumatic Diseases 2020;79:867-873.